ribavirin has been researched along with Respiratory Syndrome, Acute, Severe in 88 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 81 (92.05) | 29.6817 |
2010's | 5 (5.68) | 24.3611 |
2020's | 2 (2.27) | 2.80 |
Authors | Studies |
---|---|
Fukushi, S; Ikejiri, M; Kurane, I; Maruyama, T; Mizutani, T; Morikawa, S; Saijo, M | 1 |
Wang, Y; Zhu, LQ | 1 |
Jiang, Z; Li, W; Wang, Y; Xi, X; Zhu, Y | 1 |
Bricogne, G; Canard, B; Decroly, E; Ferron, F; Gluais, L; Imbert, I; Le, NTT; Sevajol, M; Silveira De Morais, AT; Subissi, L; Vonrhein, C | 1 |
Nau, JY | 1 |
Hui, DS; Memish, ZA; Zumla, A | 1 |
Wong, SS; Yuen, KY | 1 |
Bondarev, VP; Borisevich, SV; Loginova, SIa; Shchukina, VN | 2 |
Chan, J; Chan-Yeung, M; Cheung, TM; Ho, PL; Ip, MS; Lai, KN; Lam, B; Lam, WK; Ooi, GC; Seto, WH; Tsang, KW; Wang, T; Wong, PC; Yam, LY; Yee, WK; Yuen, KY | 1 |
Ahuja, A; Cameron, P; Chan, P; Chung, S; Hui, D; Joynt, GM; Lee, N; Leung, CB; Lui, SF; Sung, JJ; Szeto, CC; To, KF; Wu, A; Yung, MY | 1 |
Cyranoski, D | 1 |
Normile, D | 1 |
Avendano, M; Booth, CM; Cescon, DW; Chenkin, JS; Derkach, P; Detsky, AS; Dwosh, HA; Ephtimios, IE; Gold, WL; Hawryluck, LA; Kitai, I; Matukas, LM; Mazzulli, T; Mederski, BD; Poutanen, SM; Rachlis, AR; Rea, E; Rose, DB; Shadowitz, SB; Tomlinson, GA; Walmsley, SL | 1 |
Bennett, J; Hunter, J; Leszcz, M; Maunder, R; Mazzulli, T; Peladeau, N; Sadavoy, J; Steinberg, R; Verhaeghe, LM; Vincent, L | 1 |
King, S; Knowles, S; Koren, G; Phillips, E | 1 |
Cheung, TM; Lau, AC; Poon, E; So, LK; Yam, LY; Yuen, KY; Yung, RW | 1 |
Oba, Y | 1 |
Chan, PK; Cheng, WT; Chiu, MC; Chu, WC; Fok, TF; Fong, NC; Hon, KL; Kwan, YW; Leung, CW; Li, AM; Li, CK; Ng, PC; Tam, JS | 1 |
Bennett, J; Hynes-Gay, P; Jones, H; McGeer, A; Sarjoo-Devries, A | 1 |
Chi, CW; Wang, CZ | 1 |
Hui, WL; Luo, XD; Nie, QH | 1 |
Feldt, T; Göbels, K; Häussinger, D; Kroidl, A; Oette, M; Richter, J | 1 |
Chan, BH; Cheung, PC; Chiu, WK; Ip, PL; Lai, WM; Lo, KL; Luk, DC; Ma, LC; Ng, KL; Sugunan, VK | 1 |
Larkin, M | 1 |
Chow, KM; de Swiet, M; Wong, SF | 1 |
Lam, WK; Tsang, KW | 1 |
Chan, JW; Chan-Yeung, M; Ho, JC; Ho, PL; Hung, I; Ip, MS; Lai, KN; Lam, B; Lam, WK; Li, PC; Mok, TY; Ng, CK; Ooi, GC; Tsang, KW; Wong, PC | 1 |
Fok, TF; Li, AM; Ng, PC; Wong, GW | 1 |
Chan, JW; Chan, YH; Cheng, CW; Fu, CL; Lee, MP; Li, SS; Yiu, SF | 1 |
Kwok, ML; Lai, ST; Tsui, PT; Yuen, H | 1 |
Chan, PK; Cheng, FW; Cheung, HM; Chiu, MC; Chow, CB; Fok, TF; Fung, GP; Hon, EK; Lee, KH; Li, AM; Ng, PC; Peiris, MJ; Shek, CC; Tam, JS; Wong, SF; Yeung, CK | 1 |
Cheng, WF; Chiu, MC; Fong, NC; Hui, YW; Lam, YY; Leung, CW; Ng, DK; Sit, SC; Yau, EK | 1 |
Allen, U; Babyn, P; Bitnun, A; Ford-Jones, EL; Heurter, H; King, SM; Kitai, I; Manson, D; Matlow, A; Opavsky, MA; Read, S; Richardson, S; Tellier, R | 1 |
Dresser, L; Knowles, SR; Matukas, L; Phillips, EJ | 1 |
Mok, TY; Ooi, GC; Tsang, KW; Wong, PC | 1 |
Chau, TN; Chiu, MC; Choi, KW; Lai, JY; Lai, ST; Lam, BH; Lee, PO; Lim, W; Ng, TK; Tong, WL; Tsang, OT; Tso, EY; Yu, WC | 1 |
Christmann, D; Hansmann, Y; Hoen, B; Hustache-Mathieu, L; Lesens, O; Remy, V | 1 |
Moriguchi, H; Sato, C | 1 |
Bos, JC; Prins, JM; Speelman, P; van Vonderen, MG; Wertheim-van Dillen, P | 1 |
Jiao, Q; Wang, BG; Zhang, RL | 1 |
Bian, YJ; Qi, WS; Song, QQ | 1 |
Zhaori, G | 1 |
Bai, Y; Cai, BQ; Cao, B; Li, LY; Li, TS; Liu, ZY; Lu, WX; Wang, MZ; Wang, Z; Xu, WB; Xu, ZJ; Zhu, YJ | 1 |
Chang, SC; Chen, YC; Fang, CT; Sun, HY; Wang, JT | 1 |
Fujii, T; Iwamoto, A; Nakamura, T | 1 |
Ho, JC; Jones, BM; Lai, KN; Lam, B; Ma, ES; Peiris, JS; Tsang, KW; Wong, PC | 1 |
Ren, AM; Wang, BE; Zhang, SW | 1 |
Tsang, K; Zhong, NS | 1 |
Cheng, WT; Fok, TF; Hon, KL; Leung, TF; Li, AM; Li, CK; Ng, PC | 1 |
Fok, TF; Wong, GW | 1 |
Aoki, F; DiCaro, A; Feldmann, H; Jones, SM; Li, Y; Plummer, F; Ströher, U; Strong, JE | 1 |
Bossi, P; Bricaire, F; Guihot, A; Li, T | 1 |
Chan, MH; Chan, PK; Chu, CM; Chung, SS; Hui, DS; Lam, CW; Suen, MW; Sung, JJ; Wong, CK; Wong, VW | 1 |
Gold, WL; Hawryluck, L; McGeer, A; Muller, MP; Straus, SE | 1 |
Li, H; Lu, CZ; Tang, KC | 1 |
Christian, MD; Loutfy, MR; Low, DE; Muller, MP; Poutanen, SM | 1 |
Chen, XG; Cui, HJ; Duan, J; Gong, YW; Hao, YX; Hua, CJ; Li, AG; Li, P; Tong, XL; Zhang, B; Zhang, ZY; Zhen, M | 1 |
Cheung, TM; Lau, AC; Miu, FP; Poon, E; So, LK; Yam, LY; Yung, RW | 1 |
Du, XK; Hong, N | 1 |
Chan, P; Cheng, G; Cheng, Y; Hui, DS; Lee, CK; Ng, MH; Soo, YO; Sung, JJ; Tsang, KK; Wong, R | 1 |
Jiang, YY; Liu, JM; Wnag, RB | 1 |
Hui, DS; Wong, GW | 1 |
Chan, KH; Chen, F; Cheng, VC; Fan, KW; Guan, Y; Hung, IF; Jiang, Y; Kao, RY; Lee, TS; Lu, HT; Peiris, JS; Tsui, WH; Yuen, KY | 1 |
Ang, B; Earnest, A; Leo, YS; Leong, HN; Teoh, C; Xu, W | 1 |
Mok, CC; Ying, KY | 1 |
Chang, SC; Chen, HL; Chen, SY; Chiang, BL; Hsueh, PR; Kao, CL; Liu, IJ; Sheng, WH; Wang, JT; Wang, WK; Yang, CF; Yang, PC | 1 |
Chan-Yeung, M; Ho, JC; Ho, PL; Khong, PL; Ko, C; Lam, B; Lam, WK; Ooi, GC; Tsang, KW; Wu, AY; Zhong, NS | 1 |
Chiu, WK; Leung, CW | 1 |
Cinatl, J; Doerr, HW; Michaelis, M; Morgenstern, B | 1 |
Chang, HW; Hsueh, PR; Huang, JW; Kan, WC; Tsai, HB; Wu, KD; Wu, VC; Yang, YF | 1 |
Law, TS; Li, YK; Pang, WK; Shum, TT; Wong, CY; Wong, KY | 1 |
Balasingam, S; Catchpole, A; Chan, C; Lambkin, R; Oxford, JS | 1 |
Johann-Liang, R; Marcus, KA; Powers, JH | 1 |
Gao, GF; Jin, L; Li, Y; Shi, M; Wang, FS; Wang, M; Wu, H; Xu, D; Zhang, Z; Zhou, X | 1 |
Buttrey, MJ; Chiou, HE; Kuo, HP; Kuo, HT; Liu, CL; Liu, HW; Lu, YT | 1 |
Koren, G; Rezvani, M | 1 |
Peng, L; Qu, F; Wan, J; Wu, Q; Xia, Y | 1 |
Chan, KS; Chu, CM | 1 |
Guéry, B; Yazdanpanah, Y | 1 |
Bailey, K; Barnard, DL; Carson, DA; Cottam, HB; Day, CW; Heiner, M; Hoopes, J; Lauridsen, L; Lee, J; Li, JK; Montgomery, R; Sidwell, RW; Winslow, S | 1 |
Chang, SG; Chao, CL; Chen, YM; Chien, LC; Chou, P; Ho, MS; Hsu, CH; Hwang, KC; Ker, CC; Lin, JG | 1 |
Chen, M; Layon, AJ; Li, S; Li, Y; Wang, R; Zhang, X; Zhang, Y | 1 |
Meanwell, NA; Yeung, KS | 1 |
Dresser, L; Loeb, M; Louie, M; Mazzulli, T; McGeer, A; Muller, MP; Raboud, J; Rea, E; Richardson, SE | 1 |
Tai, DY | 1 |
Chan, PK; Lo, AW; Ng, HK; Sung, JJ; Tang, JW; To, KF | 1 |
20 review(s) available for ribavirin and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019.
Topics: Adolescent; Age Factors; Antiviral Agents; Child; Child, Preschool; China; Chloroquine; Coronavirus Infections; COVID-19; Female; Humans; Indoles; Infant; Infant, Newborn; Interferon-alpha; Lopinavir; Male; Pandemics; Pharmaceutical Services; Pneumonia, Viral; Practice Guidelines as Topic; Prognosis; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Treatment Outcome | 2020 |
Severe acute respiratory syndrome vs. the Middle East respiratory syndrome.
Topics: Age Distribution; Animals; Antiviral Agents; Camelus; Chiroptera; Coronavirus; Coronavirus Infections; Cross Infection; Diagnosis, Differential; Disease Progression; Female; Humans; Immunity, Innate; Infectious Disease Incubation Period; Interferons; Lung; Male; Middle East; Mycophenolic Acid; Public Health; Radiography; Real-Time Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Sex Distribution; Viral Load | 2014 |
The management of coronavirus infections with particular reference to SARS.
Topics: Anti-Inflammatory Agents; Antibodies, Viral; Antiviral Agents; Humans; Interferon Type I; Interferon-alpha; Patient Isolation; Recombinant Proteins; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Steroids | 2008 |
[Experience with empirical treatment of severe acute respiratory syndrome due to coronavirus, genotype IV].
Topics: Antiviral Agents; Drug Therapy, Combination; Humans; Lopinavir; Ribavirin; Ritonavir; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome | 2011 |
[Present state of in vitro and in vivo studies on efficacy of medical nonspecific protective agents with respect to genotype IV coronavirus causing severe acute respiratory syndrome].
Topics: Animals; Antiviral Agents; China; Chlorocebus aethiops; Disease Reservoirs; Humans; Interferon beta-1b; Interferon Inducers; Interferon-alpha; Interferon-beta; Lopinavir; Ribavirin; Russia; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells; Virus Replication | 2011 |
[The biological characteristics of SARS virus and its related coronaviruses].
Topics: Animals; Antiviral Agents; Asia, Eastern; Coronavirus; Gene Expression Regulation, Viral; Genome, Viral; Humans; Ribavirin; RNA, Messenger; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Structural Proteins | 2003 |
Advances in clinical diagnosis and treatment of severe acute respiratory syndrome.
Topics: Antiviral Agents; Gastroenterology; Glucocorticoids; Humans; Methylprednisolone; Respiration, Artificial; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Severe acute respiratory syndrome in children.
Topics: Antiviral Agents; Child; Humans; Infection Control; Public Health; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Severe acute respiratory syndrome (SARS) in Hong Kong.
Topics: Antiviral Agents; Diagnosis, Differential; Disease Outbreaks; Hong Kong; Humans; Infection Control; Patient Isolation; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Ribavirin in the treatment of severe acute respiratory syndrome (SARS).
Topics: Animals; Antiviral Agents; Clinical Trials as Topic; Disease Models, Animal; Humans; In Vitro Techniques; Mice; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Antiviral treatment of SARS: can we draw any conclusions?
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hemolysis; Humans; Interferon-alpha; Male; Ribavirin; Severe Acute Respiratory Syndrome; Steroids | 2003 |
Current concepts in SARS treatment.
Topics: Antiviral Agents; Clinical Trials as Topic; Disease Outbreaks; Humans; Hydrocortisone; Interferons; Respiration, Artificial; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
SARS: pharmacotherapy.
Topics: Algorithms; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Drug Combinations; Humans; Lopinavir; Pyrimidinones; Ribavirin; Ritonavir; Severe Acute Respiratory Syndrome | 2003 |
[Severe acute respiratory syndrome: a singular epidemic of viral pneumonia].
Topics: Adrenal Cortex Hormones; Animals; Antiviral Agents; Asia; Canada; China; Communicable Diseases, Emerging; Europe; Hong Kong; Humans; Oxygen; Patient Isolation; Prognosis; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Virus Cultivation | 2004 |
Severe acute respiratory syndrome.
Topics: Antiviral Agents; China; Communicable Diseases, Emerging; Disease Outbreaks; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; World Health Organization | 2004 |
Advancements in the battle against severe acute respiratory syndrome.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Antiviral Agents; Humans; Interferons; Lopinavir; Protease Inhibitors; Pyrimidinones; Ribavirin; Ritonavir; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Vaccines | 2004 |
Clinical picture, diagnosis, treatment and outcome of severe acute respiratory syndrome (SARS) in children.
Topics: Antiviral Agents; Humans; Prognosis; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Sensitivity and Specificity; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed | 2004 |
New antiviral drugs, vaccines and classic public health interventions against SARS coronavirus.
Topics: Animals; Antiviral Agents; Asia; Cats; Chlorocebus aethiops; Humans; Phylogeny; Public Health; Rats; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells; Viral Vaccines | 2005 |
[Antiretroviral drugs in severe acute respiratory syndrome].
Topics: Anti-HIV Agents; Anti-Retroviral Agents; Antiviral Agents; Clinical Trials as Topic; Cohort Studies; Drug Therapy, Combination; HIV Infections; Humans; Lopinavir; Protease Inhibitors; Pyrimidinones; Ribavirin; Ritonavir; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Fusion Proteins | 2006 |
Recent developments in the virology and antiviral research of severe acute respiratory syndrome coronavirus.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Chiroptera; Disease Models, Animal; Genome, Viral; Humans; Membrane Glycoproteins; Peptide Hydrolases; Ribavirin; RNA, Small Interfering; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Spike Glycoprotein, Coronavirus; Viral Envelope Proteins; Viral Proteins; Viral Vaccines | 2007 |
7 trial(s) available for ribavirin and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
[Controlled clinical study on 49 patients of SARS treated by integrative Chinese and Western medicine].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Levofloxacin; Male; Methylprednisolone; Middle Aged; Ofloxacin; Phytotherapy; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
[Evaluation on effect of integrative medical treatment on quality of life of rehabilitation stage in 85 patients with SARS].
Topics: Adolescent; Adult; Aged; Convalescence; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Middle Aged; Ofloxacin; Phytotherapy; Quality of Life; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
[Clinical study on treatment of severe acute respiratory syndrome by integrative Chinese and Western medicine].
Topics: Adult; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Methylprednisolone; Middle Aged; Phytotherapy; Ribavirin; Severe Acute Respiratory Syndrome; Single-Blind Method | 2004 |
[Clinical observation on treatment of SARS with combination of chaihu droplet pill and huoxiang zhengqi droplet pill].
Topics: Adult; Creatine Kinase; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; L-Lactate Dehydrogenase; Male; Methylprednisolone; Middle Aged; Phytotherapy; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Retrospective comparison of convalescent plasma with continuing high-dose methylprednisolone treatment in SARS patients.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiviral Agents; Convalescence; Drug Therapy, Combination; Female; Humans; Male; Methylprednisolone; Middle Aged; Plasma; Pulse Therapy, Drug; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome | 2004 |
The lesson of supplementary treatment with Chinese medicine on severe laboratory-confirmed SARS patients.
Topics: Adolescent; Adult; Antiviral Agents; Clarithromycin; Combined Modality Therapy; Drugs, Chinese Herbal; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Lung; Male; Methylprednisolone; Middle Aged; Radiography; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Taiwan | 2006 |
Symptom combinations associated with outcome and therapeutic effects in a cohort of cases with SARS.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antiviral Agents; Arthralgia; China; Cohort Studies; Combined Modality Therapy; Drug Therapy, Combination; Female; Glucocorticoids; Hemofiltration; Houttuynia; Humans; Length of Stay; Male; Medicine, Chinese Traditional; Middle Aged; Oxygen Inhalation Therapy; Oxyhemoglobins; Phytotherapy; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Thymosin | 2006 |
61 other study(ies) available for ribavirin and Respiratory Syndrome, Acute, Severe
Article | Year |
---|---|
Synthesis and biological evaluation of nucleoside analogues having 6-chloropurine as anti-SARS-CoV agents.
Topics: Animals; Antiviral Agents; Chemistry, Pharmaceutical; Chlorocebus aethiops; Dose-Response Relationship, Drug; Drug Design; Evaluation Studies as Topic; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleosides; Purines; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells | 2007 |
Assessment of the efficacy and safety of Ribavirin in treatment of coronavirus-related pneumonia (SARS, MERS and COVID-19): A protocol for systematic review and meta-analysis.
Topics: Antiviral Agents; Betacoronavirus; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Humans; Meta-Analysis as Topic; Middle East Respiratory Syndrome Coronavirus; Pandemics; Pneumonia, Viral; Research Design; Ribavirin; SARS-CoV-2; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Systematic Reviews as Topic; Treatment Outcome | 2020 |
Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA.
Topics: Antiviral Agents; Coronavirus; Crystallography, X-Ray; Exoribonucleases; Humans; Methyltransferases; Models, Molecular; Protein Binding; Protein Domains; Ribavirin; RNA, Viral; Severe Acute Respiratory Syndrome; Viral Nonstructural Proteins; Virus Replication | 2018 |
[Emergency treatment for Middle Eastern coronaviruses (MERS-CoV].
Topics: Animals; Antiviral Agents; Coronavirus; Diagnosis, Differential; Drug Therapy, Combination; Emergency Treatment; Humans; Interferon-alpha; Middle East; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2013 |
A cluster of cases of severe acute respiratory syndrome in Hong Kong.
Topics: Adrenal Cortex Hormones; Adult; Aged; Antiviral Agents; Contact Tracing; Disease Outbreaks; Drug Therapy, Combination; Female; Hong Kong; Humans; Lung; Male; Middle Aged; Radiography; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
A major outbreak of severe acute respiratory syndrome in Hong Kong.
Topics: Adult; Antiviral Agents; Autopsy; Chills; Contact Tracing; Disease Outbreaks; Drug Therapy, Combination; Female; Fever; Glucocorticoids; Hong Kong; Humans; L-Lactate Dehydrogenase; Lung; Male; Middle Aged; Multivariate Analysis; Prednisolone; Prognosis; Radiography; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome | 2003 |
Critics slam treatment for SARS as ineffective and perhaps dangerous.
Topics: Drug Therapy, Combination; Hong Kong; Humans; Inflammation; Ribavirin; Severe Acute Respiratory Syndrome; Steroids; Treatment Outcome | 2003 |
Infectious diseases. Battling SARS on the frontlines.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Chlamydia Infections; Communicable Diseases, Emerging; Disease Outbreaks; Drug Therapy, Combination; Hong Kong; Humans; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Steroids | 2003 |
Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiviral Agents; Biomarkers; Communicable Diseases, Emerging; Comorbidity; Cough; Demography; Disease Outbreaks; Disease Progression; Dyspnea; Female; Fever; Hospitalization; Humans; Hydrocortisone; Infection Control; Intensive Care Units; Lung; Male; Middle Aged; Ontario; Proportional Hazards Models; Radiography; Respiration, Artificial; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Statistics, Nonparametric; Survival Analysis | 2003 |
The war against an unknown pathogen: rising to the SARS challenge.
Topics: Aged; Antiviral Agents; Canada; Disease Outbreaks; Humans; Practice Guidelines as Topic; Ribavirin; Seasons; Severe Acute Respiratory Syndrome; Travel | 2003 |
The immediate psychological and occupational impact of the 2003 SARS outbreak in a teaching hospital.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Cross Infection; Disease Outbreaks; Drug Therapy, Combination; Health Personnel; Hospitalization; Hospitals, Teaching; Humans; Mass Screening; Occupational Diseases; Ribavirin; Severe Acute Respiratory Syndrome; Social Support; Steroids; Stress, Psychological | 2003 |
Ribavirin in the treatment of SARS: A new trick for an old drug?
Topics: Antiviral Agents; Creatinine; Erythrocytes; Humans; Phosphorylation; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Development of a standard treatment protocol for severe acute respiratory syndrome.
Topics: Adult; Anti-Bacterial Agents; Drug Administration Schedule; Female; Humans; Male; Methylprednisolone; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2003 |
The use of corticosteroids in SARS.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Drug Therapy, Combination; Humans; Respiratory Distress Syndrome; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Clinical presentations and outcome of severe acute respiratory syndrome in children.
Topics: Administration, Oral; Adolescent; Adult; Age Factors; Cefotaxime; Child; Child, Preschool; Clarithromycin; Disease Outbreaks; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hong Kong; Humans; Infant; Injections, Intravenous; Lung; Lymphopenia; Methylprednisolone; Oxygen Inhalation Therapy; Prednisolone; Prospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
Severe acute respiratory syndrome. The Mount Sinai experience.
Topics: Adult; Air Pressure; Anti-Infective Agents; Antiviral Agents; Canada; Female; Glucocorticoids; Humans; Infection Control; Methylprednisolone Hemisuccinate; Ofloxacin; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2003 |
[SARS--the facts. Transmission, diagnosis and managing suspected cases].
Topics: Cause of Death; Cross-Sectional Studies; Diagnosis, Differential; Disease Outbreaks; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Humans; Hydrocortisone; Infusions, Intravenous; Microscopy, Electron; Patient Isolation; Quarantine; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2003 |
Severe acute respiratory syndrome in children: experience in a regional hospital in Hong Kong.
Topics: Adolescent; Adrenal Cortex Hormones; Age Factors; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Female; Hong Kong; Humans; Infant; Male; Methylprednisolone; Radiography, Thoracic; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Sex Factors; Tomography, X-Ray Computed; Treatment Outcome | 2003 |
SARS treatment: who will lead the way forward?
Topics: Drug Design; Humans; Interferons; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Severe Acute Respiratory Syndrome and pregnancy.
Topics: Abortion, Induced; Antiviral Agents; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Outcome; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome; Steroids | 2003 |
Management of severe acute respiratory syndrome: the Hong Kong University experience.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hong Kong; Humans; Male; Middle Aged; Patient Care Planning; Recurrence; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Treatment Outcome | 2003 |
High-dose pulse versus nonpulse corticosteroid regimens in severe acute respiratory syndrome.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antiviral Agents; Cohort Studies; Female; Humans; Male; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2003 |
Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study.
Topics: Acute Disease; Adult; Aged; Antiviral Agents; Combined Modality Therapy; Convalescence; Diastole; Echocardiography; Echocardiography, Doppler, Pulsed; Female; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Respiration, Artificial; Ribavirin; Severe Acute Respiratory Syndrome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2003 |
Severe acute respiratory syndrome: clinical outcome and prognostic correlates.
Topics: Adult; Aged; Aged, 80 and over; Antiviral Agents; Communicable Diseases, Emerging; Female; Humans; Male; Middle Aged; Pneumonia; Prognosis; Respiration, Artificial; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2003 |
Infants born to mothers with severe acute respiratory syndrome.
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Cesarean Section; Cohort Studies; Disease Outbreaks; Enterocolitis, Necrotizing; Female; Fetal Growth Retardation; Hong Kong; Humans; Ileal Diseases; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Intestinal Perforation; Jejunal Diseases; Male; Methylprednisolone; Pregnancy; Pregnancy Complications, Infectious; Respiratory Distress Syndrome, Newborn; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2003 |
A young infant with severe acute respiratory syndrome.
Topics: Age of Onset; Anti-Bacterial Agents; Antiviral Agents; China; Drug Therapy, Combination; Humans; Infant; Infant, Newborn; Infant, Premature; L-Lactate Dehydrogenase; Leukocytosis; Male; Neutrophils; Radiography; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Children hospitalized with severe acute respiratory syndrome-related illness in Toronto.
Topics: Adolescent; Antiviral Agents; Asia; Child; Child, Hospitalized; Child, Preschool; Clarithromycin; Cohort Studies; Disease Outbreaks; Disease Transmission, Infectious; Female; Hospitals, Pediatric; Humans; Infant; Male; Ontario; Prospective Studies; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Travel | 2003 |
Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Antiviral Agents; Canada; Disease Outbreaks; Female; Humans; Hypocalcemia; Male; Middle Aged; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Severe acute respiratory syndrome: Relapse? Hospital infection?
Topics: Antiviral Agents; Cross Infection; Female; Hong Kong; Humans; Middle Aged; Recurrence; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
[Severe acute respiratory syndrome (SARS). The questions raised by the management of a patient in Besançon and Strasbourg].
Topics: Aircraft; Anti-Inflammatory Agents; Antiviral Agents; China; Coronavirus; Coronavirus Infections; Diagnosis, Differential; Disease Outbreaks; Drug Therapy, Combination; France; Humans; Hydrocortisone; Lung; Male; Middle Aged; Patient Isolation; Patient Readmission; Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Travel | 2003 |
Treatment of SARS with human interferons.
Topics: Drug Therapy, Combination; Humans; Interferon Type I; Interferons; Recombinant Proteins; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2003 |
[Clinical diagnosis, treatment and prognosis of elderly SARS patients].
Topics: Age Factors; Aged; Antiviral Agents; Diabetes Complications; Female; Humans; Hypertension; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome | 2003 |
Treatment of severe acute respiratory syndrome in health-care workers.
Topics: Clinical Protocols; Cross Infection; Health Occupations; Humans; Infection Control; Infectious Disease Transmission, Patient-to-Professional; Methylprednisolone; Occupational Diseases; Ribavirin; Severe Acute Respiratory Syndrome | 2003 |
Prolonged disturbances of in vitro cytokine production in patients with severe acute respiratory syndrome (SARS) treated with ribavirin and steroids.
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Antiviral Agents; Cells, Cultured; Cytokines; Drug Therapy, Combination; Female; Humans; Leukocyte Count; Leukocytes; Lymphocyte Activation; Lymphocyte Subsets; Male; Middle Aged; Phytohemagglutinins; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Ribavirin for SARS in children.
Topics: Adolescent; Antiviral Agents; Child; Child, Preschool; Coronavirus; Female; Humans; Infant; Male; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Severe acute respiratory syndrome (SARS) in children.
Topics: Antiviral Agents; Child; Disease Outbreaks; Humans; Infection Control; Patient Isolation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2004 |
Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha.
Topics: Animals; Antigens, Viral; Antiviral Agents; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Humans; Immunoblotting; Interferon alpha-2; Interferon-alpha; Microscopy, Phase-Contrast; Recombinant Proteins; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Vero Cells | 2004 |
Serum LD1 isoenzyme and blood lymphocyte subsets as prognostic indicators for severe acute respiratory syndrome.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antigens, CD; Antimetabolites; Area Under Curve; Biomarkers; Female; Humans; Hydrocortisone; Isoenzymes; L-Lactate Dehydrogenase; Leukocyte Count; Lymphocyte Subsets; Male; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Clinical trials and novel pathogens: lessons learned from SARS.
Topics: Antiviral Agents; Clinical Trials as Topic; Communicable Diseases, Emerging; Disease Outbreaks; Humans; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Serum hepatic enzyme manifestations in patients with severe acute respiratory syndrome: retrospective analysis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine Transaminase; Antiviral Agents; Aspartate Aminotransferases; Child; Female; Humans; Incidence; L-Lactate Dehydrogenase; Liver; Liver Diseases; Liver Function Tests; Male; Middle Aged; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
Outcome of coronavirus-associated severe acute respiratory syndrome using a standard treatment protocol.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Combined Modality Therapy; Comorbidity; Female; Humans; Male; Methylprednisolone; Middle Aged; Prospective Studies; Pulse Therapy, Drug; Radiography; Respiration, Artificial; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2004 |
Avascular necrosis of bone in severe acute respiratory syndrome.
Topics: Adult; Antiviral Agents; Female; Femur Head Necrosis; Glucocorticoids; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Osteonecrosis; Prednisolone; Radiography; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome | 2004 |
[Effect of integrative Chinese and western medicine on T-lymphocyte subsets in treating patients with severe acute respiratory syndrome].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Humans; Male; Methylprednisolone; Middle Aged; Phytotherapy; Ribavirin; Severe Acute Respiratory Syndrome; T-Lymphocyte Subsets | 2004 |
In vitro susceptibility of 10 clinical isolates of SARS coronavirus to selected antiviral compounds.
Topics: Adult; Antiviral Agents; Cell Line; Chlorogenic Acid; Drug Synergism; Female; Flavonoids; Glycyrrhizic Acid; Humans; Interferon beta-1a; Interferon-alpha; Interferon-beta; Lopinavir; Male; Microbial Sensitivity Tests; Middle Aged; Pyrimidinones; Ribavirin; Rimantadine; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Viral Plaque Assay | 2004 |
Investigational use of ribavirin in the treatment of severe acute respiratory syndrome, Singapore, 2003.
Topics: Adult; Antiviral Agents; Female; Hospital Mortality; Humans; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2004 |
Lupus pneumonitis or severe acute respiratory syndrome?
Topics: Adult; Antiviral Agents; China; Community-Acquired Infections; Diagnosis, Differential; Female; Humans; Lupus Erythematosus, Systemic; Methylprednisolone; Middle Aged; Ofloxacin; Pneumonia; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2004 |
Temporal relationship of viral load, ribavirin, interleukin (IL)-6, IL-8, and clinical progression in patients with severe acute respiratory syndrome.
Topics: Adult; Antiviral Agents; Female; Humans; Interleukin-6; Interleukin-8; Male; Middle Aged; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Time Factors; Viral Load | 2004 |
Pentaglobin in steroid-resistant severe acute respiratory syndrome.
Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Drug Resistance; Female; Humans; Immunoglobulin A; Immunoglobulin M; Male; Middle Aged; Radiography; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome | 2004 |
High-dose hydrocortisone reduces expression of the pro-inflammatory chemokines CXCL8 and CXCL10 in SARS coronavirus-infected intestinal cells.
Topics: Animals; Anti-Inflammatory Agents; Antimetabolites; Cell Line, Tumor; Chemokine CXCL10; Chemokines; Chemokines, CXC; Chlorocebus aethiops; Colonic Neoplasms; DNA; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation, Neoplastic; Hydrocortisone; Inflammation; Interleukin-8; Intestines; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Time Factors; Up-Regulation; Vero Cells | 2005 |
Renal hypouricemia is an ominous sign in patients with severe acute respiratory syndrome.
Topics: Carrier Proteins; Drug Administration Schedule; Female; Humans; Immunoglobulins, Intravenous; Kidney Diseases; Male; Methylprednisolone; Middle Aged; Organic Anion Transporters; Ribavirin; Severe Acute Respiratory Syndrome; Treatment Outcome; Uric Acid | 2005 |
Tuberculosis in a SARS outbreak.
Topics: Adolescent; Alanine Transaminase; Antiviral Agents; Disease Outbreaks; Female; Fever; Hong Kong; Humans; Lung; Ribavirin; Severe Acute Respiratory Syndrome; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pulmonary | 2004 |
Ribavirin trials and hantavirus--what we should not conclude.
Topics: Antiviral Agents; Controlled Clinical Trials as Topic; Hantavirus Pulmonary Syndrome; Humans; Reproducibility of Results; Ribavirin; Sample Size; Severe Acute Respiratory Syndrome | 2005 |
Longitudinal alteration of circulating dendritic cell subsets and its correlation with steroid treatment in patients with severe acute respiratory syndrome.
Topics: Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme 2; Antibodies, Viral; Base Sequence; Blood Cell Count; Carboxypeptidases; Dendritic Cells; Female; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Ribavirin; RNA, Viral; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; T-Lymphocyte Subsets; Time Factors | 2005 |
Adverse effects of ribavirin and outcome in severe acute respiratory syndrome: experience in two medical centers.
Topics: Adult; Anemia; Antiviral Agents; Chi-Square Distribution; Communicable Diseases, Emerging; Female; Humans; Hypoxia; Logistic Models; Male; Middle Aged; Retrospective Studies; Ribavirin; Risk Factors; Severe Acute Respiratory Syndrome; Statistics, Nonparametric; Taiwan; Treatment Outcome | 2005 |
Pregnancy outcome after exposure to injectable ribavirin during embryogenesis.
Topics: Adult; Antiviral Agents; Embryonic Development; Female; Humans; Injections, Intramuscular; Pregnancy; Pregnancy Outcome; Ribavirin; Severe Acute Respiratory Syndrome | 2006 |
Photolabeling probes of ribavirin and EICAR.
Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Crystallography, X-Ray; Hepacivirus; Hepatitis C; Humans; Imidazoles; Light; Models, Chemical; Models, Molecular; Molecular Biology; Nucleosides; Photoaffinity Labels; Photolysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Time Factors; Triazoles | 2005 |
Ribavarin should be tested in clinical trials in combination with other antiviral agents for severe acute respiratory syndrome.
Topics: Antiviral Agents; Cause of Death; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Needs Assessment; Ribavirin; Risk Assessment; Severe Acute Respiratory Syndrome; Survival Rate | 2005 |
Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.
Topics: Animals; Antiviral Agents; Caco-2 Cells; Cell Survival; Chlorocebus aethiops; Cytokines; Cytopathogenic Effect, Viral; Female; Humans; IMP Dehydrogenase; Lung; Mice; Mice, Inbred BALB C; Mycophenolic Acid; Oligonucleotide Array Sequence Analysis; Ribavirin; Ribonucleosides; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Specific Pathogen-Free Organisms; Vero Cells; Virus Replication | 2006 |
Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome.
Topics: Adrenal Cortex Hormones; Adult; Adverse Drug Reaction Reporting Systems; Anemia; Antiviral Agents; Bradycardia; Canada; Cohort Studies; Disease Outbreaks; Dose-Response Relationship, Drug; Female; Humans; Injections, Intravenous; Magnesium Deficiency; Male; Medical Records Systems, Computerized; Middle Aged; Retrospective Studies; Ribavirin; Severe Acute Respiratory Syndrome; Tetany; Treatment Outcome | 2007 |
Pharmacologic treatment of SARS: current knowledge and recommendations.
Topics: Adrenal Cortex Hormones; Antiviral Agents; Clinical Competence; Disease Outbreaks; Global Health; Humans; Immunoglobulins; Immunologic Factors; Interferons; Lopinavir; Practice Guidelines as Topic; Protease Inhibitors; Pyrimidinones; Ribavirin; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus | 2007 |
Quantitative temporal-spatial distribution of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) in post-mortem tissues.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme 2; Antiviral Agents; Autopsy; Cadaver; Female; Glyceraldehyde-3-Phosphate Dehydrogenases; Humans; Hydrocortisone; Male; Middle Aged; Peptidyl-Dipeptidase A; Ribavirin; RNA, Viral; Severe Acute Respiratory Syndrome; Severe acute respiratory syndrome-related coronavirus; Time Factors; Viral Load | 2007 |